Research Use Only — Confirm to Continue

OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.

By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.

Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

5-Amino-1MQ Dosage & Reconstitution

5-amino-1-methylquinolinium. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

100 mg/mL · 100000 mcg/mL
All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — 5-Amino-1MQYour Answer

100Draw To This Line
1That's This Many mL
0Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 100
50 mg ÷ 0.5 mL = 100 mg/mL  →  100 mg ÷ 100 mg/mL = 1 mL  →  × 100 = 100 units
Your dose is bigger than the whole vial. Double-check the vial size, or pick a larger one.

2Week-By-Week Plan — 5-Amino-1MQ

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Low reported 50 mg 1× daily 0.5 mL 50 u 1 doses
Standard 100 mg 1× daily 1 mL 100 u — doses
Upper reported 150 mg 1× daily 1.5 mL 150 u ⚠ — doses
Weeks until the top dose
4 weeks
Peptide used getting there
2100 mg
Vials you'll need
42 × 50 mg
Once you're at the top dose
4200 mg / 4 wk · 84 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — 5-Amino-1MQ

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Weeks 1–2 50 mg daily 0.5 mL 50 u 14 700 mg
Weeks 3–4 100 mg daily 1 mL 100 u 14 1400 mg
Week 5 onward
per 4 weeks from here on
150 mg daily 1.5 mL 150 u ⚠ 28 4200 mg
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About 5-Amino-1MQAbout This Peptide

Metabolic / Incretin
Also known as
5-amino-1-methylquinolinium
Class
Metabolic / Incretin
Route
Subcutaneous
Half-life
Not well characterised
Evidence tier
Preclinical

A small-molecule NNMT inhibitor rather than a true peptide. Research data show reduced adiposity in diet-induced obesity models. No human trials. Commonly grouped with the peptides even though it is a different class of molecule.

Buy 5-Amino-1MQthis peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
Small-molecule NNMT inhibitor reverses diet-induced obesity in mice Neelakantan H, et al. Biochemical Pharmacology, 2018
The primary preclinical result behind all downstream claims.
Find on PubMed ↗
Nicotinamide N-methyltransferase in metabolic regulation Kraus D, et al. Nature, 2014
Establishes NNMT as a metabolic target.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

AOD-9604

A C-terminal fragment of human growth hormone investigated as an anti-obesity agent. Human trials were conducted, but efficacy on …

SLU-PP-332

An estrogen-related receptor pan-agonist described as an exercise mimetic in preclinical models. Not a peptide, no human data of a…

All 71 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.